Oxaliplatin in Rectal Cancer
NCT00259363
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
46
Enrollment
INDUSTRY
Sponsor class
Stopped
Study cancelled because recruitment rate was too slow
Conditions
Rectal Neoplasms
Interventions
DRUG:
Oxaliplatin
Sponsor
Sanofi